大宏立 reported revenue of ¥0.22B for the period ended 2026-06-30, +21.8% year on year. Net income was ¥0.03B, a 13.0% net margin on a 35.9% gross margin. The largest revenue line is 破碎设备 at 39% of the total. Free cash flow for the period was ¥0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.22B | +21.8% |
| Gross profit | ¥0.08B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.03B | +213.6% |
| Gross margin | 35.9% | Net margin 13.0% |
| Revenue Q/Q | +60.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 破碎设备 | ¥0.09B | 39.5% |
| 配件 | ¥0.05B | 24.7% |
| 其他主营业务 | ¥0.04B | 18.5% |
| 筛分设备 | ¥0.04B | 16.0% |
| 其他(补充) | ¥0.00B | 1.3% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.14B | 64.1% |
| R&D | ¥0.00B | 2.0% |
| SG&A | ¥0.04B | 20.2% |
| Tax & other | ¥0.00B | 2.1% |
| Item | Amount |
|---|---|
| Total assets | ¥1.17B |
| Total liabilities | ¥0.29B |
| Shareholders' equity | ¥0.89B |
| Equity / assets | 75.7% |
| Operating cash flow | ¥0.01B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.01B |
| Cash conversion (OCF / net income) | 151% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
圣元环保 ・ 杰美特 ・ 康泰医学 ・ 欧陆通 ・ 回盛生物 ・ 天阳科技 ・ 海晨股份 ・ 捷强装备 ・ 蒙泰高新 ・ 金春股份 ・ 维康药业 ・ 大叶股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies